Products & Services · Sales to customers (Note 9)
SPINE & OTHER — Sales to customers (Note 9)
Johnson & Johnson SPINE & OTHER — Sales to customers (Note 9) decreased by 0.6% to $694.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.4%, from $671.00M to $694.00M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2017
Last reportedQ1 2026Apr 22, 2026
Rolls up toTotal Revenue
How to read this metric
An increase indicates growing market adoption or successful product launches in the orthopedic sector, while a decrease may signal competitive pressure or reduced procedure volumes.
Detailed definition
This metric represents the total revenue generated from the sale of products within the spine, sports medicine, and rela...
Peer comparison
Comparable to revenue segments for orthopedic and surgical device divisions at major medical technology competitors.
Metric ID:
jnj_segment_spine_sports_other_sales_to_customers_note_9Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $777.00M | $706.00M | $712.00M | $724.00M | $708.00M | $729.00M | $766.00M | $710.00M | $752.00M | $743.00M | $696.00M | $671.00M | $727.00M | $698.00M | $694.00M |
| QoQ Change | — | -9.1% | +0.8% | +1.7% | -2.2% | +3.0% | +5.1% | -7.3% | +5.9% | -1.2% | -6.3% | -3.6% | +8.3% | -4.0% | -0.6% |
| YoY Change | — | — | — | -6.8% | +0.3% | +2.4% | +5.8% | +0.3% | +3.2% | -3.0% | -2.0% | -10.8% | -2.2% | +0.3% | +3.4% |
Range$671.00M – $777.00M
CAGR-3.2%
Avg YoY Growth-0.8%
Median YoY Growth+0.3%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's spine & other — sales to customers (note 9)?
- Johnson & Johnson (JNJ) reported spine & other — sales to customers (note 9) of $694.00M in Q1 2026.
- How has Johnson & Johnson's spine & other — sales to customers (note 9) changed year-over-year?
- Johnson & Johnson's spine & other — sales to customers (note 9) increased by 3.4% year-over-year, from $671.00M to $694.00M.
- What does spine & other — sales to customers (note 9) mean?
- Total revenue earned from the sale of spine and sports medicine medical devices.